21 Sept 2020
According to research presented at the European Society for Medical Oncology's virtual conference (ESMO), a new hormonal breast cancer treatment which includes the substance abemaciclib may reduce recurrence by up to 25%.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024